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The Bordetella master virulence regulatory system, BvgAS, controls a spectrum of gene expression states,
including the virulent Bvg phase, the avirulent Bvg phase, and at least one Bvg-intermediate (Bvgi) phase.
We set out to define the species- and strain-specific features of this regulon based on global gene expression
profiling. Rather than functioning as a switch, Bvg controls a remarkable continuum of gene expression states,
with hundreds of genes maximally expressed in intermediate phases between the Bvg and Bvg poles.
Comparative analysis of Bvg regulation in B. pertussis and B. bronchiseptica revealed a relatively conserved
Bvg phase transcriptional program and identified previously uncharacterized candidate virulence factors. In
contrast, control of Bvg- and Bvgi-phase genes diverged substantially between species; regulation of meta-
bolic, transporter, and motility loci indicated an increased capacity in B. bronchiseptica, compared to B.
pertussis, for ex vivo adaptation. Strain comparisons also demonstrated variation in gene expression patterns
within species. Among the genes with the greatest variability in patterns of expression, predicted promoter
sequences were nearly identical. Our data suggest that the complement of transcriptional regulators is largely
responsible for transcriptional diversity. In support of this hypothesis, many putative transcriptional regula-
tors that were Bvg regulated in B. bronchiseptica were deleted, inactivated, or unregulated by BvgAS in B.
pertussis. We propose the concept of a “flexible regulon.” This flexible regulon may prove to be important for
pathogen evolution and the diversification of host range specificity.
Bordetellae are gram-negative bacteria that colonize ciliated
respiratory epithelial surfaces of a variety of hosts (9). Borde-
tella bronchiseptica causes infections that are typically chronic
and often asymptomatic in a broad range of animals (21).
Numerous phylogenetic and genomic analyses (see, e.g., refer-
ences 13, 43, and 59) have indicated this species to be the
progenitor of human-restricted agents of acute respiratory dis-
ease in humans: B. pertussis, which causes whooping cough in
children and coughing illness in adolescents and adults (63),
and B. parapertussis, which confers similar but milder clinical
symptoms (22). Despite vaccination, B. pertussis remains a ma-
jor cause of childhood mortality worldwide and is reemerging
in some highly vaccinated populations (7, 42, 63). Even though
Bordetella species are closely related at the nucleotide se-
quence level, they differ in several respects, such as severity of
disease and host range specificity. B. pertussis likely evolved
from a B. bronchiseptica-like ancestor primarily through ge-
nome decay (13, 43). Differential gene expression and coding
polymorphisms within expressed loci appear to be the primary
determinants of species-specific phenotypes (9, 20, 43).
Expression of nearly all known Bordetella virulence and col-
onization factors is controlled by the BvgAS signal transduc-
tion system (reviewed in reference 8). In response to a variety
of environmental signals, the BvgS transmembrane sensor ki-
nase initiates a multistep phosphorylation cascade that ulti-
mately leads to phosphorylation of the DNA-binding response
regulator BvgA. Rather than functioning as an on/off switch,
BvgAS controls a spectrum of at least three distinct gene ex-
pression states along a regulatory continuum (11). When
BvgAS is fully active (Bvg phase), B. bronchiseptica and B.
pertussis express nearly identical sets of toxins and adhesins,
including filamentous hemagglutinin, pertactin, fimbriae, and
adenylate cyclase toxin. The transcription of a type III secre-
tion system (TTSS) locus is also Bvg activated in both species,
although the synthesis of TTSS proteins appears to be post-
transcriptionally blocked specifically in B. pertussis (36). A key
difference in Bvg-activated gene expression is the pertussis
toxin locus (ptx/ptl), the coding sequences of which are intact in
both species but expressed only in the Bvg phase of B. per-
tussis (2). Motility loci in B. bronchiseptica (1) and virulence-
repressed genes (vrg genes) in B. pertussis (31) are expressed
when Bvg is inactive (Bvg phase). Some genes, such as bipA,
are maximally expressed between the Bvg and Bvg poles
(Bvg-intermediate phase [Bvgi]) (15, 53).
While the Bvg phases of B. bronchiseptica and B. pertussis
appear to be adapted to respiratory tract colonization, the
Bvg phase of B. bronchiseptica promotes survival under nu-
trient-limiting conditions (1, 10, 34, 44). The Bvg phase of B.
pertussis is still relatively uncharacterized, and because B. per-
tussis is apparently unable to persist outside the host, this phase
* Corresponding author. Mailing address: VA Palo Alto Health
Care System, 154T, Bldg. 101, C4-151, 3801 Miranda Ave., Palo Alto,
CA 94304. Phone: (650) 493-5000, ext. 66991. Fax: (650) 852-3291.
E-mail: cummings@cmgm.stanford.edu.
† Supplemental material for this article may be found at http://jb
.asm.org/.
‡ C.A.C. and H.J.B. contributed equally to this work.
§ Present address: Laboratory of Pediatric Infectious Diseases,
Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen,
The Netherlands.
1775
 o
n
 July 13, 2012 by Universiteitsbibliotheek
http://jb.asm.org/
D
ow
nloaded from
 
has been proposed to be an evolutionary remnant (9, 40). The
Bvgi phase is thought to be similar in B. bronchiseptica and B.
pertussis (17) and may be involved in biofilm formation (25)
and aerosol transmission (11, 60).
Although the signals that influence BvgAS in vivo remain
unknown, Bvg-regulated gene expression can be precisely reg-
ulated in vitro: BvgS is active during growth at 37°C, but tem-
peratures below 26°C or the presence of millimolar amounts of
nicotinic acid (NA) or sulfate anion (modulating signals) ren-
der BvgS inactive (37, 41). Furthermore, bvgS “phase-locked”
mutant alleles can be used to freeze the signaling system in
specific positions along the regulatory continuum (9).
Using the complementary approaches of environmental
modulation and phase-locked mutants for global expression
analysis, we defined the full BvgAS regulons in B. pertussis and
B. bronchiseptica. By comparing the species’ expression pro-
files, we sought to identify novel virulence determinants and
discover the genetic basis of species-specific phenotypes. To
understand the pathogenic and physiological adaptations re-
quired for survival in the host environment, we explored the
dynamic Bvg-regulated transcription patterns upon environ-
mental modulation and examined regulation of transporter
repertoires and metabolic pathways. By identifying novel Bvg
and Bvgi phase genes, we sought to elucidate the roles for these
phases in the Bordetella life cycle. To assess intraspecific gene
expression diversity, we examined strain-specific Bvg regula-
tion within B. bronchiseptica and B. pertussis. Finally, by com-
paring promoter sequences and Bvg-regulated transcription
factors, we identified possible mechanisms of differential gene
expression.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains used in this study are listed in
Table 1. Bvg and Bvg phase-locked derivatives of B. pertussis were constructed
by introducing the respective bvgS alleles by allelic exchange as described pre-
viously (34). Bordetella strains were grown on BG agar (Becton Dickinson,
Franklin Lakes, NJ) supplemented with 7.5% or 15% sheep blood for B. bron-
chiseptica and B. pertussis, respectively. For RNA isolation, cultures were grown
overnight at 37°C in modified Stainer-Scholte medium (SSM) and then reinoc-
ulated into prewarmed medium at an optical density at 600 nm of approximately
0.05 to 0.1. Cultures were incubated at 37°C until they reached mid-log phase, at
which point they were harvested by centrifugation for 30 seconds. (No samples
were taken at an optical density at 600 nm exceeding 1.5, at which point the
culture is still growing logarithmically under these conditions.) For steady-state
modulation experiments, NA was added to both overnight and log-phase cultures
at the concentrations indicated below. For phase shift experiments, cultures were
grown to mid-log phase in SSM containing 75 mM magnesium sulfate, pelleted
by centrifugation, resuspended in prewarmed magnesium sulfate-free SSM, and
incubated at 37°C throughout the course of sampling.
Microarray analysis. Cy5-labeled cDNA was hybridized to spotted DNA mi-
croarrays with a Cy3-labeled reference. The reference sample for these experi-
ments was one of two preparations. In some cases a common reference mixture
of RNA samples from modulated and unmodulated B. pertussis Tohama I and B.
bronchiseptica RB50 as well as their phase-locked derivatives was labeled with
Cy3. In other cases, as described by Talaat et al. (54), we used a Cy3-labeled
genomic DNA sample comprised of a 1:1:1 mixture of the three genomes that are
represented on the array as described previously (13). All samples in a given
experiment (i.e., set of phase-locked strains, NA dose curve, or time course)
were processed using the same reference, and data obtained from the two
methods were not combined during analysis. Details on nucleic acid isolation,
labeling, and microarray construction are given in Methods in the supple-
mental material.
Background-subtracted Cy5/Cy3 intensity ratios were determined for spots
meeting quality control criteria and then averaged across replicates and normal-
ized. For comparison of phase-locked strains, a fold change cutoff of 2.1 was
chosen to select Bvg-regulated genes. This threshold was consistent with all but
the lowest fold changes of transcripts determined to be significant by significance
analysis of microarrays (57) but was more inclusive of known Bvg-regulated
genes. For modulation experiments, to be considered Bvg regulated, genes were
required to have data from all array hybridizations and a fold change between the
maximum and minimum values across the data set exceeding a threshold of 2.4
for B. bronchiseptica and 2.0 for B. pertussis. The selection of cutoffs was chosen
empirically to maximize inclusion of known Bvg-regulated genes while minimiz-
ing apparent noise. For comparison of B. bronchiseptica strains, genes with at
least three measurements per strain and a fold change of at least 2.1 were
considered regulated. Data were clustered using the self-organizing tree algo-
rithm (23), after which nodes were reordered manually based on the mean
expression profile within each node. Further details are in Methods in the
supplemental material.
Gene annotation is as described previously (43), with functional categories
according to MultiFun (50). Open reading frame (ORFs) assigned to the “vir-
ulence factors” category were reassigned to a functional class reflecting their
cellular function (see the tables in the supplemental material). MultiFun cate-
gories 7.0.0 (some information, but not classifiable) and 0.0.0 (unknown
proteins, no known homologues) were combined into the class “hypothetical
ORFs.” Metabolic pathway analysis employed Pathway Tools (29) and auto-
matically generated pathway genome databases from BioCyc (SRI Interna-
TABLE 1. Strains used in this study
Species and
strain Phenotype Genotype Parent
Source or
reference Alias Host
a
B. bronchiseptica
RB50 WT b 10 Rabbit
RB53 Bvg bvgS-C3 RB50 10
RB53i Bvgi bvgS-C3, II RB50 11
RB54 Bvg bvgS RB50 10
Bbr81 WT 59 732 Dog
Bbr77 WT 59 675 Human
B. pertussis
Tohama I WT 30 Human
ThSc3 Bvg bvgS-C3 Tohama I This study
ThdS Bvg bvgS Tohama I This study
GMT-1 WT GG 35 Human
GSc3 Bvg bvgS-C3 GMT-1 This study
BPC1.i Bvgi bvgS-C3, II GMT-1 60
GMTdS Bvg bvgS GMT-1 This study
a Host is given only for wild-type strains.
b WT, wild type.
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tional; [http://biocyc.org/BBRO518/organism-summary?objectBBRO518 and
http://biocyc.org/BPER520/organism-summary?objectBPER520]). Further an-
notation of predicted transporters was obtained from TransportDB (47).
Real-time PCR. SYBR Green real-time reverse transcription-PCR assays were
used to determine transcript levels of selected genes. The relative quantitation
method (CT) (33) was used to evaluate variation between phase-locked strains
relative to each gene examined. Further details are in Methods in the supple-
mental material.
Motif identification. Genes were first grouped into putative operons (see
Tables S1 and S2 in the supplemental material). MEME (3) was used to search
the upstream sequences of coregulated operons for conserved motifs of between
6 and 20 nucleotides (nt). Motifs discovered by this method are weighted statis-
tical models. To assess whether they were specific to the regulated operons,
multiple alignments of motifs were input to HMMer (version 1.8.4; S. R. Eddy,
Washington University [http://hmmer.wustl.edu]) in order to construct hidden
Markov models that were used to search both coregulated genes and unregulated
genes. The scores from searches against unregulated genes were used to set the
98th percentile score for each motif. Motifs with scores exceeding this threshold
in the coregulated genes were considered significant. Sequence logo displays
were created using SEQLOGO (12). Details are in Methods in the supplemental
material.
Accession numbers. Microarray data have been deposited in ArrayExpress
as E-MEXP-399, E-TABM-27, E-TABM-28, E-TABM-29, E-TABM-30, and
E-TABM-31.
RESULTS
Species-specific regulation by BvgAS. Genes expressed at
either end of the Bvg phase spectrum were identified by mi-
croarray-based transcriptional profiling of Bvg and Bvg
phase-locked derivatives of B. bronchiseptica RB50 and B. per-
tussis GMT-1 (Table 1). Data and enhanced figures are avail-
able in the supplemental material and at http://asiago.stanford
.edu/BvgAS.
Two hundred eighty-eight genes were classified as Bvg acti-
vated and 250 as Bvg repressed (Fig. 1A; see Tables S3 and S4
in the supplemental material). Twenty-nine percent of the Bvg-
activated genes were shared by RB50 and GMT-1, but 59%
were regulated only in RB50. In contrast, 86% Bvg-repressed
genes were so regulated only in RB50. Twenty-nine percent of
the genes regulated by BvgAS specifically in RB50 were pre-
sumed to be missing from or highly divergent in the GMT-1
genome based upon comparative genome hybridization anal-
ysis (Fig. 1A and data not shown). (Such genes were treated as
components of the B. bronchiseptica-specific regulon. In the
tables in the supplemental material, genes that are absent, by
comparative sequencing or comparative genome hybridization
analysis, are indicated to distinguish them from those in which
transcriptional abundance of an intact gene is being differen-
tially regulated.) Microarray data were validated by quantitative
real-time PCR assays of 38 RB50 genes and 29 GMT-1 genes.
Microarray and reverse transcription-PCR data were highly con-
cordant for RB50 (r2 0.92) (Fig. 2) and GMT-1 (r2 0.80) (not
shown).
The Bvg-activated genes of B. pertussis and B. bronchiseptica
were similarly distributed among functional categories and
were enriched for genes predicted to encode proteins involved
in folding and ushering and in transport and proteins expressed
on the cell surface (see Fig. S1 in the supplemental material).
The expected preferential expression of known virulence fac-
tors in the Bvg phase in both species was corroborated (see
Table S5 in the supplemental material). Of the fimbrial major
subunit genes, fim2 and fimA were Bvg-activated genes in both
species, but fim3, fimX, fimN, and BB3424 were Bvg activated
only in RB50.
Genes coregulated with bona fide virulence factors may be
candidate virulence determinants, particularly if sequence mo-
tifs suggest a direct role in pathogenesis. Eight autotransporter
genes, including five encoding known virulence factors, were
Bvg activated in both species, and two more were Bvg activated
in B. bronchiseptica. Several iron acquisition genes were Bvg
activated, though the cultures were not iron-depleted, suggest-
ing that Bvg phase Bordetella is primed for iron acquisition
prior to actual iron restriction. A gene for an aerolysin/pertus-
sis toxin domain-containing protein (BB3242/BP1251), a po-
tential novel toxin, was Bvg activated in both species.
Three putative adhesin genes, i.e., fhaS, fhaL, and BB0110,
were Bvg activated in RB50 but not GMT-1. The lipid A
palmitoyl transferase gene, pagP, was Bvg activated in RB50,
consistent with prior results (45), but was not regulated in
GMT-1. Other RB50-specific Bvg-activated genes included
genes encoding protein-folding catalysts, catalase, and a DegP
family serine protease (MucD), suggesting that B. bronchiseptica
may be more resistant to environmental stress in the Bvg
FIG. 1. Distribution of differentially expressed genes. The distribu-
tions of Bvg-activated and Bvg-repressed genes among B. bronchiseptica
RB50 and B. pertussis GMT-1 (A), three B. bronchiseptica strains (B), and
two B. pertussis strains (C) are shown. Areas within Venn diagrams are
drawn approximately to scale, and the number of ORFs in each is indi-
cated. In parentheses are numbers of genes absent from the other ge-
nome(s) as determined by genome sequence comparison (RB50 and
Tohama I) or comparative genome hybridization (GMT-1).
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phase. Of note, two Bvg-activated loci in RB50 were Bvg re-
pressed in GMT-1: osmB, encoding a lipoprotein, and a cluster
of three hypothetical ORFs.
Consistent with previous results, the ptx/ptl locus was strongly
upregulated in the Bvg phase of GMT-1 but not in RB50, in
which the promoter is inactive regardless of Bvg phase (2). Other
B. pertussis-specific Bvg-activated genes included an outer mem-
brane porin gene (BP0267) and a TonB-dependent iron trans-
porter gene (bfrE).
Bvg-repressed genes were found almost exclusively in B.
bronchiseptica. Only 13 genes were Bvg repressed in both spe-
cies (Fig. 1A), including several genes in the wlb locus, which
is required for synthesis of the lipopolysaccharide (LPS) tri-
saccharide. Phase-specific expression of this locus may contrib-
ute to the preferential production of O-antigen-containing LPS
in the Bvg phase (45, 58).
Consistent with previous studies (1), the chemotaxis and
flagellar machinery was strongly induced in the B. bronchisep-
tica Bvg phase (see Fig. S1 in the supplemental material).
Other B. bronchiseptica-specific Bvg-repressed genes of inter-
est are predicted to encode two autotransporters, two iron
acquisition proteins, and a 340-kDa protein (BB1186) with
multiple hemolysin-type calcium-binding repeats and an asso-
ciated secretion system. Five genes from the putative capsule
biosynthesis locus were upregulated in the Bvg phase of B.
pertussis only, implying phase-specific capsule production.
Patterns of BvgAS-regulated gene expression upon environ-
mental modulation. The initial experiments assayed the ex-
treme ends of the Bvg phase spectrum and failed to account
fully for genes such as bipA that are maximally expressed dur-
ing other, intermediate phases of Bvg activity. To identify such
intermediate-phase genes, expression profiles of Bvgi phase-
locked strain derivatives of RB50 and GMT-1 were deter-
mined (see Table S6 in the supplemental material). This ap-
proach yielded only a few genes with transcript profiles similar
to that of bipA, including a gene predicted to encode a prob-
able thiolase (BB4250/BP0422) and, in RB50 only, a predicted
phenylacetic acid (paa) degradation operon. Because the use
of strains locked at only one intermediate state of Bvg activa-
tion may not fully reveal all intermediate-phase genes, we
pursued an independent and complementary approach.
Cultures can be experimentally held at any point along the
BvgAS activation continuum by chemically modulating BvgS
activity (e.g., with NA). The pattern of Bvg-regulated gene
expression observed in a series of cultures with decreasing
concentrations of modulator is recapitulated in the time-de-
pendent pattern of gene expression following a shift from mod-
ulating to nonmodulating conditions (reviewed in reference 9).
For example, early Bvg-activated genes (e.g., fhaB) are ex-
pressed immediately after a shift and at intermediate concen-
trations of modulator, while late Bvg-activated genes (e.g., ptx)
are expressed at later time points (2 hours or more) after the
shift and only at very small amounts of modulator. Here, we
use the terms “early” and “late” to describe patterns gleaned
from both steady-state modulation and time-dependent shift
experiments.
Transcription abundance profiles of RB50 and GMT-1
grown in increasing amounts of NA were determined. Isogenic
strain derivatives with a constitutive bvgS allele (Bvgc) were
also analyzed to identify genes that respond to NA indepen-
dently of BvgAS.
(i) B. bronchiseptica. In vitro modulation of RB50 revealed
remarkably diverse transcript patterns falling into five domi-
nant gene expression classes (Fig. 3). Bvg-repressed, two
classes of Bvg-intermediate, and early and late Bvg-activated
gene classes were discerned, each with subtle but clear differ-
ences in expression patterns. Most Bvg-repressed genes, in-
cluding motility and chemotaxis loci, were expressed in the
presence of 0.8 mM or more NA, but expression of a few
genes, including an ABC transporter locus, was activated only
at the highest concentration of NA (20 mM).
The earliest Bvg-activated genes, expressed at NA concen-
trations of up to 0.8 mM, included bvgAS, fhaB and fimA
(members of the same operon), and a putative adhesin gene
(BB0110). The cya operon, prn, and other fim genes were
expressed at up to 0.6 mM NA, while most remaining Bvg-
activated genes, including the TTSS locus, were expressed only
at NA concentrations of less than or equal to 0.4 mM. These
data suggest a trend in which adhesins are expressed early,
whereas toxins and the TTSS are expressed later.
The expression pattern of the prototypical intermediate-
phase gene bipA, peaking at 0.6 and 0.8 mM NA, was virtually
unique, with only a few loci showing a similar profile. However,
69 genes, including the paa locus and part of the trp locus, were
maximally expressed at 0.4 to 0.6 mM NA (Fig. 3, Bvgi-a), and
another class of 193 genes displayed maximum expression at
0.8 and 1.2 mM NA (Fig. 3, Bvgi-b). Though conceptually
similar, the expression peaks for each of these two distinct
intermediate regulatory classes occurred at nonoverlapping
concentrations of NA. We refer to these Bvg-regulatory phases
and their corresponding gene classes as “Bvgi-a” and “Bvgi-b”
to distinguish them from the specific point on the Bvg spec-
trum represented by the Bvgi phase-locked mutation.
FIG. 2. Validation of B. bronchiseptica microarray data by real-time
PCR. Ratios of transcript abundance in RB53 (Bvg) versus RB54
(Bvg), obtained by microarray analysis (x axis) or real-time PCR
( y axis). Red, Bvg activated; green, Bvg repressed. Selected genes are
shown for illustrative purposes.
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(ii) B. pertussis. In B. pertussis GMT-1, the Bvg regulatory
continuum was assessed both by steady-state NA modulation
and by shifting from the Bvg to the Bvg phase following
withdrawal of magnesium sulfate from the culture medium.
Both treatments resulted in a broad spectrum of expression
states that were separable into four dominant gene classes
(Fig. 4).
The Bvg phase gene expression patterns largely paralleled
those of RB50, with a few notable differences. As in B. bron-
chiseptica, regulatory (bvgAS and bvgR) and adhesin (fhaB and
prn) genes were expressed earlier than the TTSS, autotrans-
porter, and toxin (cya and ptx) genes. Modulation of GMT-1
yielded only a small number of Bvg-repressed genes, expres-
sion of which was turned off 90 min after shift or in the pres-
ence of 1.2 mM or less NA. These included wlbD and the
capsule polysaccharide locus.
A few genes were maximally expressed between the Bvg
and Bvg phases, but only a putative thiolase gene (BP0422)
showed a bipA-like expression pattern. Expression of 33 genes
peaked at 30 min postshift and increased slightly in the range
of 0.4 to 1.2 mM NA (Fig. 4, Bvgi-a). The Bvg intermediate
gene set in GMT-1 was much less extensive than that in RB50
and, except for bipA and BP0422, showed little overlap with the
set in RB50.
Regulation of metabolic pathways by BvgAS. In B. bronchi-
septica, genes related to carbon metabolism and transport
functions are dynamically regulated across the Bvg continuum.
Bvg phase transcript profiles suggested increased activity of
the tricarboxylic acid (TCA) cycle. Upregulation of C4-dicar-
boxylate, tricarboxylate, and branched-chain amino acid trans-
porters might indicate increased concentrations of TCA inter-
mediates and amino acids that can be degraded to acetyl
coenzyme A. The rate of conversion of glycine to C1 units, used
to build coenzyme A, may be increased by expression of the
glycine cleavage system (gcvTHP). Increased expression of ar-
ginase (BB0805) may accelerate the urea cycle, yielding fuma-
rate that can be converted to malate by another Bvg-repressed
FIG. 3. Patterns of Bvg-regulated gene expression in B. bronchiseptica
RB50. Within each experiment, data are centered and shown from Bvg
(left) to Bvg (right). Rows correspond to array probes, and columns
correspond to experiments. , phase-locked Bvg; i, phase-locked Bvgi;
, phase-locked Bvg. Red, increased transcript abundance; green, de-
creased transcript abundance; black, no significant change in transcript
abundance; gray, no data. NA concentrations (millimolar) are indicated
along the bottom. The five major gene expression classes, with some
representative loci, and the Bvg-independent NA-induced class are indi-
cated on the right. Purple arrowhead, bipA. The set of genes represented
by the gray bar on the right passed filtering criteria but showed no dis-
cernible pattern.
FIG. 4. Patterns of Bvg-regulated gene expression in B. pertussis
GMT-1. Data are centered within each experiment. Results obtained
with NA modulation and phase-locked strain analysis are shown from
Bvg (left) to Bvg (right), whereas the phase shift experiment is
depicted from Bvg (left) to Bvg (right). Rows correspond to array
probes, and columns correspond to experiments. , phase-locked
Bvg; i, phase-locked Bvgi; , phase-locked Bvg. Red, increased
transcript abundance; green, decreased transcript abundance; black,
no significant change in transcript abundance; gray, no data. NA con-
centrations (millimolar) and time elapsed after shift (minutes) are
indicated along the bottom. The four major gene expression classes,
with some representative loci, and the Bvg-independent NA-induced
class are indicated on the right. Purple arrowhead, bipA. The set of
genes represented by the gray bar on the right passed filtering criteria
but showed no discernible pattern.
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gene, fumarate hydratase (BB4081). A concordant increase in
urea production may explain the observed increase in urease
gene expression.
Bvg phase transcript profiles indicated a shift in carbon
source preference: increased abundance of glutamine trans-
porter (glnHPQ) and glutamate decarboxylase gene transcripts
suggests uptake of glutamine and conversion to glutamate,
which may be metabolized to TCA cycle reactants. Lactate and
fatty acids appear to be preferred alternative carbon sources,
as both L-lactate dehydrogenase and enoyl coenzyme A hy-
dratase genes were upregulated. A shift in nitrogen source
preference was also apparent. Expression of glnHPQ, together
with the upregulation of an ammonia transporter gene (amtB)
suggest that the organism is optimized for uptake of glutamine
and ammonia in the Bvg phase. Ammonia is a readily avail-
able source of nitrogen at the airway epithelial surface (16).
In addition to a role in nutrition, glnHPQ upregulation might
also affect virulence, as glnQ mutant group B streptococci are
deficient in both epithelial cell binding and infection of an
animal model (55).
Regulation by BvgAS of genes encoding respiratory elec-
tron transport chain components was evident. In the Bvg
phase, gene transcripts for NADH dehydrogenase, L-lactate
dehydrogenase, and a putative cytochrome c protein were
more abundant, while those for components of the cyto-
chrome bc1 complex, two putative cytochromes, and two
ferredoxins were preferentially expressed in the Bvg phase.
In the Bvgi-a phase, genes that encode components of cyto-
chrome bd and cytochrome cbb3 were maximally expressed.
Both of these terminal oxidases have very high affinity for
oxygen and are maximally transcribed under microaerophilic
conditions in other bacteria (see e.g., reference 56). Other
electron carriers and cytochrome biosynthetic proteins, as
well as a cytochrome-containing periplasmic nitrate reductase
(napDABC) implicated in adaptation to anaerobic environ-
ments (51), were also preferentially expressed in the Bvgi-a
phase.
Regulation of metabolic and transport functions by BvgAS
was much less apparent in B. pertussis. The only such compo-
nents of the B. pertussis Bvg phase transcript pattern shared
with B. bronchiseptica were the amtB ammonium transporter
gene and the heme biosynthesis locus. Nutrient transporter
operons and cytochrome complex genes were not Bvg regu-
lated in GMT-1. These results suggested that the physiological
state of B. pertussis is not appreciably regulated by BvgAS and
may help to explain the inability of B. pertussis to survive in
nutrient-limited environments.
Intraspecies variation in BvgAS regulation. Differences in Bvg-
regulated gene expression between Bordetella species prompted
the examination of differential regulation among isolates of the
same species. Different regulatory patterns within a species might
reflect ongoing microevolution and could cast light upon mecha-
nisms of host adaptation. Diversification of gene expression pro-
files may also influence pathogenicity, as has been recently sug-
gested for Mycobacterium tuberculosis (18).
Bvg-regulated gene expression in RB50 (isolated from a
rabbit) was compared to that in phylogenetically distant strains
isolated from a human (Bbr77) and from a dog (Bbr81), which
were grown in the presence or absence of NA to induce the
Bvg and Bvg phases, respectively. Comparison of Bvg-reg-
ulated genes revealed a surprising amount of diversity among
the three isolates (Fig. 1B; see Fig. S2 in the supplemental
material). Of 268 genes that were Bvg activated in at least one
strain, only 74 were similarly regulated in all three strains.
Several genes that are predicted to encode factors involved in
protein folding and ushering (dsbA, dsbG, and BB3803) and
bfrD, encoding a putative TonB-dependent iron receptor, were
among these genes (Fig. 5A). These also included most known
and suspected virulence factors, including seven autotransport-
ers and the TTSS, as well as BB0110, encoding a putative
adhesin, and BB3242, encoding a putative toxin. Notable ex-
ceptions were fhaS, fimX, and BB0450, which were activated to
a lesser extent in Bbr81, and dnt, which is missing from the
Bbr77 genome and does not appear to be regulated in Bbr81.
The strain-specific Bvg-activated genes were rather evenly dis-
tributed among most nonessential functional classes (Fig. 5A)
and included risA (only in RB50) and bipA and ompQ (only in
RB50 and Bbr77).
Of 254 genes that were Bvg repressed in at least one strain,
only 73 were similarly regulated in all three strains. These
included chemotaxis, motility, LPS biosynthesis, sulfate utili-
zation, and carbon metabolism loci (Fig. 5A). Strain-specific
Bvg-repressed genes were distributed over many functional
classes, with substantial diversity in expression of genes related
to small-molecule degradation and transport (Fig. 5A). Finally,
seven genes were Bvg activated in one strain and Bvg repressed
in another. In most cases, the gene was not Bvg regulated in
the third strain.
In order to investigate B. pertussis strain-specific BvgAS regu-
lation, GMT-1, a recent clinical strain, was compared to Tohama
I, a strain isolated before widespread pertussis vaccination and
subsequently maintained as a laboratory strain. Bvg and Bvg
phase-locked derivatives of Tohama I were analyzed as described
for GMT-1. Many differences between strains were observed,
particularly in the Bvg phase, in which only 23 of the 113 genes
repressed in Tohama I were also repressed in GMT-1 (Fig. 1C;
see Fig. S4 in the supplemental material). The conserved Bvg-
repressed genes mainly belonged to cell envelope, small-molecule
degradation, and hypothetical categories (Fig. 5B). Among the
strain-specific Bvg-repressed genes were the previously described
but functionally uncharacterized vrg6, vrg18, vrg24, and vrg73 (31),
which were Bvg repressed only in Tohama I. Another notable
difference between strains was a more extensive and complete
Bvg repression of the capsule locus in Tohama I.
Sixty percent of the total B. pertussis Bvg-activated genes
were similarly regulated in the two B. pertussis strains (Fig. 1C).
Like in B. bronchiseptica, the predominant functional classes
among this group were folding and ushering, cell envelope, and
transport (Fig. 5B). Most known virulence factors and auto-
transporters that are present in the B. pertussis genome, in-
cluding the TTSS, were Bvg activated by both strains, as was
BB3242, encoding a putative toxin. Interestingly, fimX, fhaS,
and dnt were Bvg activated only in Tohama I. fim3 was Bvg
activated in GMT-1 but Bvg repressed in Tohama I, as previ-
ously described (24).
Mechanisms of differential transcriptional regulation. (i)
Comparative analysis of putative transcriptional regulatory
sequences. Species- or strain-specific differences in Bvg regu-
lation of a given locus have at least three plausible explana-
tions, with the trivial one being the absence of the gene from
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one of the genomes. Differential expression of genes present in
both genomes can be attributed to either sequence divergence
in cis-regulatory regions or variation in the levels, activity, or
encoding of transcriptional regulatory proteins.
Among 61 loci that were differentially regulated between RB50
and Tohama I, 41 were present in both genomes. Five of the loci
that were Bvg activated specifically in RB50 had either an IS481
element or a prophage near the 5 end of the ORF in Tohama I,
suggesting that the cis-regulatory domains have been disrupted or
rearranged in Tohama I (see Table S7 in the supplemental ma-
terial). At two loci, fim3 and BB2270/BP1793, large gaps distin-
guished the B. bronchiseptica and B. pertussis upstream regions,
implicating cis-regulatory variation as a likely determinant of dif-
ferential regulation. Twenty-five of the upstream intergenic re-
gions differed only by single-nucleotide gaps or mismatches, with
nucleotide identities ranging from 93.7% to 99.5%. The remain-
ing eight putative promoter regions were identical in the two
genomes. For identical upstream regions and, most likely, those
with a small number of mismatches, differential regulation can
probably be attributed to variation in expression or activity of a
transcriptional regulator.
(ii) Bvg-regulated transcription factors. Not all Bvg-regu-
lated genes are directly regulated by the binding of BvgA to
their promoters (9). Bvg-regulated expression of downstream
regulators may lead to fine-tuning of the virulence program,
for example, by influencing timing of gene expression or inte-
grating environmental signals.
Genes for the known downstream regulators, BvgR (39) and
BtrS (36), and 10 other putative transcriptional regulators were
found to be Bvg activated in both B. bronchiseptica RB50 and
B. pertussis Tohama I (see Table S8 in the supplemental ma-
terial). Genes for 3 putative regulators were Bvg activated
specifically in Tohama I, while those for 15 regulators, 8 of
which are absent or interrupted in Tohama I, were Bvg acti-
vated only in RB50. Eighteen RB50 genes for transcriptional
regulators, 11 of which are absent or interrupted in Tohama I,
were Bvg repressed, while only 1 was Bvg repressed in Tohama
I. As many as 11 transcriptional regulator genes, 7 of which are
deleted or disrupted in the B. pertussis genome, were maxi-
mally expressed in B. bronchiseptica in the presence of inter-
mediate NA concentrations, of which only btr was regulated in
B. pertussis. Comparison of the sequences upstream of the
FIG. 5. Functional categorization of ORFs in core and flexible BvgAS regulons. Bvg-regulated genes (red, Bvg activated; green, Bvg repressed)
were grouped by functional categories (43, 50). Data are expressed as the percentage that is regulated by BvgAS among all annotated ORFs in
each class. (A) B. bronchiseptica. ORFs in the core regulon were Bvg regulated by strains RB50, Bbr77, and Bbr81. Those in the flexible regulon
were Bvg regulated in either one or two of the three strains. (B) B. pertussis. ORFs in the core regulon were Bvg regulated by strains GMT-1 and
Tohama I. Those in the flexible regulon were Bvg regulated in only one of the two strains.
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differentially expressed regulatory genes that are intact in both
species revealed perfect conservation at four loci and a mini-
mum of 97% identity for the others (see Table S7 in the
supplemental material), suggesting that divergence in cis-reg-
ulatory motifs is not likely to be solely responsible for the
observed differences in expression. We propose that the spe-
cies-specific differences in Bvg-regulated global transcriptional
profiles are largely due to the deletion and inactivation in
Tohama I of more than two dozen transcriptional regulators
that are Bvg regulated in RB50.
Differential expression of transcriptional regulators between
strains of the same species was also observed. Genes for seven
putative regulatory proteins that were Bvg activated in either
Tohama I or GMT-1 were differentially regulated between the
two isolates (see Table S8 in the supplemental material).
Among B. bronchiseptica isolates, 22 likely transcriptional reg-
ulatory protein genes that were Bvg activated, and 13 that were
Bvg repressed, were differentially regulated. Thus, transcrip-
tional regulation of downstream regulators by BvgAS can vary
dramatically from strain to strain, which may profoundly affect
global transcriptional profiles and the phenotypes conferred.
(iii) Identification of putative regulatory motifs. Although
the binding of BvgA to a few virulence factor gene promoters
has been well characterized, little is known about regulatory
control of most Bvg-regulated genes. To identify putative cis-
regulatory sequences, the upstream regions of Bvg-regulated
transcription units were searched for common motifs by using
the pattern detection algorithm MEME (3). Motifs that were
significantly enriched among an expression class were identi-
fied by comparing the distributions of motif scores in the up-
stream regions of Bvg-regulated versus Bvg-unregulated genes.
Some regions upstream of Bvg-activated and Bvg-repressed
genes were enriched for motifs reminiscent of the traditional
BvgA-binding consensus site (TTT[C/G]NTA) and suggestive
of an inverted repeat. A weighted statistical model constructed
from high-scoring putative BvgA half-sites identified the ex-
perimentally confirmed high-affinity BvgA-binding sites in the
promoters of bvgA, fhaB, cyaA, and bipA (4, 15, 27, 28) (see
Table S9 in the supplemental material). These sites consisted
of a high-scoring heptad adjacent to a lower scoring inverted
heptad (Fig. 6A). A putative binding motif was found upstream
of prn and 11 other Bvg-activated RB50 genes and of 6 other
Bvg-activated Tohama I genes at an average distance of 168 nt
from the predicted start codon. The majority of the putative
BvgA-binding motifs identified by this approach did not con-
tain substitutions in their high-scoring heptads that have been
shown to abolish in vivo activity of the fhaB promoter (6).
However, several of the motifs did harbor such substitutions
(e.g., A, T, or G instead of C in position 4), suggesting that
these motifs may not actually represent functional BvgA-bind-
ing sites (see Table S9 in the supplemental material).
In the upstream regions of genes that were Bvg activated at
early time points, the half-sites of the predicted BvgA-binding
site were adjacent, while upstream of late Bvg-activated genes,
the half-sites tended to be separated by one or two bases,
suggesting that extra bases between the half-sites may reduce
affinity for BvgA dimers and lead to delayed transcriptional
activation. The BvgA motif model also identified the high-
affinity binding site in the bipA promoter and putative sites
upstream of nine other RB50 Bvgi-a and Bvgi-b phase genes.
Putative BvgA-binding sites were also found upstream of
Bvg-repressed genes (see Table S9 in the supplemental mate-
rial). However, sites from Bvg and Bvg phase genes were
indistinguishable (data not shown) and distances to the pre-
dicted start codons were similar, suggesting that the putative
BvgA-binding site position relative to the core promoter may
not determine activation versus repression. We speculate that
BvgA may act as a transcriptional repressor, even when bound
far upstream of the core promoter, implying a different mech-
anism than the RNA polymerase interference proposed for
repression of bipA (15, 62).
Surprisingly, only 11% of the Bvg and Bvg phase gene
upstream regions possessed discernible high-affinity BvgA-
binding sites as defined by the motif model, suggesting that the
actual BvgA-binding motif may be highly degenerate, an inter-
pretation supported by the failure of this model to identify a
BvgA-binding site in the bvgR and ptx promoters, both of which
bind BvgA (5, 38). Alternatively, expression of many Bvg-
regulated genes may be governed by downstream transcrip-
tional regulators.
A motif corresponding to the Fim box (48) (Fig. 6B) was
found upstream of all fimbrial major subunit genes except
fimA, as well as four other RB50 Bvg-activated genes (fhaS,
tcfA, the glutamate decarboxylase gene, and an autotrans-
porter gene) and two Tohama I Bvg-activated genes (vag8 and
bapC), suggesting that these confirmed and likely virulence
factors may be coregulated with fimbriae. Although fim3 is Bvg
repressed in Tohama I, the promoter has an intact Fim box.
This motif was also found upstream of three RB50 Bvg-re-
pressed genes as well as the Tohama I Bvg-repressed capsular
polysaccharide locus promoter, suggesting that its cognate
binding factor may promote transcriptional repression as well
as activation.
Among the 25 RB50 Bvgi-a phase operons, a single motif was
present in seven upstream regions, including those of several
respiratory complex loci (Fig. 6C). This highly conserved, palin-
FIG. 6. Putative cis-regulatory motifs. Multiple alignments are rep-
resented as sequence logos. x axis, nucleotide position within motif;
y axis, bit score. Arrows indicate putative half-sites. (A) BvgA-binding
motif from regions upstream of Bvg-activated genes. Dashed line,
variable-length (0- to 2-nt) spacer between half-sites. (B) Fim box.
Solid lines, box 1 and box 2; dashed line, beginning of poly(C) tract.
(C and D) FNR box (C) and palindromic motif (D) from regions
upstream of Bvgi-b genes.
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dromic motif corresponds to the FNR box, the binding site for
Fnr, a highly conserved transcriptional regulator that controls
respiration pathways under low-oxygen conditions in Escherichia
coli and a number of other bacterial species (52). The Bordetella
homologue of Fnr, Btr, was coexpressed with its putative target
genes, suggesting that Btr may activate these genes.
Among the promoters of RB50 loci maximally expressed at
0.8 to 1.2 mM NA, three palindromic motifs were identified,
together accounting for 15% of the genes in this class. One of
these motifs (Fig. 6D) has the length and spacing typically
observed for LysR family transcription factor-binding sites,
suggesting that it might be the recognition site for one of the
several LysR family proteins maximally expressed in this phase.
Overall, putative regulatory motifs that were significantly
overrepresented among the Bvg-regulated gene class were
identified upstream of only one-third of the Bvg-regulated
genes. This relatively low percentage of Bvg-regulated loci may
reflect degeneracy of recognition sites, cooperativity between
multiple poorly conserved sites, or the existence of many small
subregulons, each with a unique regulator. Identifying the cis-
regulatory sequences of the remaining loci will require further
exploration, and validation of the sites described here will
require direct experimentation.
DISCUSSION
Differentiation of Bvg-regulated gene expression. Compara-
tive global expression analysis revealed unexpected complexity
of the Bordetella BvgAS regulon and insights into possible
evolutionary paths for virulence regulation among strains and
species of an important group of bacterial pathogens. In par-
ticular, B. bronchiseptica, a pathogen and persistent commensal
in a broad set of animal species, displayed a wide variety of
gene expression profiles in vitro. These profiles may reflect
spatially and/or temporally defined patterns during the infec-
tious cycle. The spatial model proposes that colonization of
different airway niches and the process of transmission require
overlapping yet distinct sets of gene products, the expression of
which is regulated by BvgAS in response to environmental
conditions characteristic of those anatomic locations. Alterna-
tively, or in addition, BvgAS may regulate a gene expression
program in a temporally defined manner, facilitating the es-
tablishment of infection (49). The steady-state modulation and
phase shift experiments described in this study can be consid-
ered in vitro counterparts of the spatial and temporal models,
respectively. Although these models are not necessarily mutu-
ally exclusive, expression of metabolic genes, especially respi-
ratory chain components, suggests that the phases are tuned to
different environmental niches, favoring spatially defined reg-
ulation.
Patterns of Bvg-activated gene expression in B. bronchisep-
tica and B. pertussis were similar, emphasizing that the Bvg
phase serves similar functions in their respective life cycles.
The differentially expressed Bvg-activated genes identified
here are candidate determinants of Bordetella host specificity.
For example, B. bronchiseptica-specific expression of the puta-
tive adhesin BB0110 and several fim genes could contribute to
its wider host range compared to B. pertussis.
In contrast, the Bvg phases of the two species were remark-
ably different. In B. bronchiseptica, the multitude of Bvg-re-
pressed metabolic, transport, motility, and chemotaxis loci sug-
gests that this phase is optimized for nutrient scavenging and
survival ex vivo. However, these gene classes have been shown
to be important for in vivo survival in other systems (see, e.g.,
references 14 and 26), so a role for the Bvg phase within the
host cannot be ruled out. The number and diversity of B.
pertussis Bvg phase genes were limited, reflecting either a
different function for the Bvg phase or the loss of expression,
subsequent to host restriction, of loci that facilitate survival ex
vivo. The near-complete discordance of Bvg phase expression
patterns of B. pertussis strains GMT-1 and Tohama I supports
the latter scenario, as lack of selective pressure is likely to
result in random loss and heterogeneity of Bvg phase factors.
These data support the suggestion that the B. pertussis Bvg
phase is an evolutionary remnant (9, 40). Of note, B. bronchi-
septica strains also differed in Bvg phase expression patterns,
but to a lesser extent than B. pertussis, possibly reflecting a
preference of these strains for different ex vivo niches or re-
dundancy in the Bvg-repressed gene repertoire or, alterna-
tively, suggesting partial random degradation of the Bvg
phase in this species as well.
This is the most extensive comparative analysis of the Bor-
detella transitional phases along the Bvg regulatory continuum.
Prior to this study, with the exception of a few genes (see, e.g.,
references 15, 46, and 49), expression patterns between the
Bvg and Bvg phases had not been determined. Only a single
intermediate-phase gene, bipA, had been identified, and the
Bvgi phases of B. pertussis and B. bronchiseptica were thought
to be fairly similar. In our study, features of the intermediate
Bvg phases were among the more unexpected findings. In B.
bronchiseptica RB50 there are at least two distinct gene expres-
sion states between the Bvg and Bvg poles, comprising 262
genes. These genes may facilitate survival in different environ-
mental niches through activation of specific metabolic and
transport pathways. An even higher-resolution examination of
the Bvg regulation spectrum may reveal further distinct phe-
notypic phases. The ability of BvgAS to transduce environmen-
tal signals into a series of discrete gene expression states could
also be a feature of other regulatory systems. However, be-
cause gene regulation studies have historically focused on the
endpoints of the spectrum, this has, as yet, remained unrecog-
nized. We propose that examination of transcriptional profiles
of other regulatory systems at intermediate levels of environ-
mental signals may reveal regulatory spectra analogous to that
described here for BvgAS.
Because intermediate-phase gene expression patterns were
found to differ significantly between the two species, these
phases may provide species-specific functions in addition to the
putative roles in aerosol transmission and biofilm formation
(25, 60). Preferential expression in the Bvgi-a phase of B.
bronchiseptica of genes for respiratory terminal oxidases with
high oxygen affinity suggests that this phase may be optimized
for survival in microaerophilic conditions, which may be en-
countered at the airway epithelium due to the accumulation of
mucus and debris. B. pertussis intermediate-phase expression
patterns did not group into discrete classes as in B. bronchi-
septica, nor did they suggest an obvious physiological role,
suggesting that this phase may be an evolutionary remnant in
B. pertussis.
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Exploring the flexible regulon. This study joins a growing num-
ber of reports (see, e.g., references 18, 19, and 61) in demonstrat-
ing that global transcript or protein profiles among strains of the
same species can be highly variable. Consequently, gene expres-
sion data from a single strain may not reflect the prevailing ex-
pression profile of that species. For example, the most frequently
studied B. pertussis Bvg-repressed genes were identified in the B.
pertussis type strain 18-323 (31), yet the present data did not
reveal Bvg repression of any of these loci in GMT-1, raising the
question of whether Bvg-regulated expression of these genes is a
feature of modern clinical isolates.
Among strains of a single microbial species, genomic content
can vary substantially (32). Genes that are present in all iso-
lates (i.e., the “core genome”) are assumed to be phylogeneti-
cally conserved, while those that are variably present (i.e., the
“flexible genome”) are proposed to be horizontally acquired or
differentially lost within the species. The components of the
flexible genome are thought to confer differences in pheno-
types such as virulence and host range. We favor an analogous
distinction for the description of gene regulation patterns
found in related strains in response to a stimulus and propose
that a global gene expression profile comprises a “core regu-
lon” that is shared among all strains and a “flexible regulon”
that varies between strains. Regulated expression of each gene
in the core regulon is presumed to be required by every isolate
of a species. For a pathogen grown under conditions that
promote virulence, the core regulon includes factors that are
required for efficient infection and transmission. Therefore,
components of the core regulon are the best candidate vaccine
or therapeutic targets. On the other hand, regulated expression
of the genes in the flexible regulon is not required by every
strain, and variation in the expression of these genes is toler-
ated within the population. In a pathogen population, the
flexible regulon could include determinants of host specificity,
thus facilitating its spread into new hosts or, conversely, its
restriction to a single host. More generally, the flexible regulon
could reflect adaptation to specific habitats by subpopulations.
We believe that differentially expressed loci are an informative
class of Bvg-regulated genes and may prove critical in our
understanding of evolution and diversification of host range
specificity between and within Bordetella species.
One important determinant of the flexible regulon is the
collection of downstream transcriptional regulators that are
themselves regulated, directly or indirectly, by the core top-
level regulators. Because each transcription factor may be ca-
pable of modifying the expression patterns of many individual
loci, a single mutation that changes the concentration or ac-
tivity of a regulator can have widespread effects on the global
expression pattern. Indeed, we observed differential regulation
of many putative transcriptional regulators, both within and
between Bordetella species. This variability in regulatory pro-
tein repertoires could represent an efficient and powerful way
to generate phenotypic diversity during evolution and may be
one of the predominant mechanisms of differential gene ex-
pression in the bordetellae.
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